Compliance Hotline

anonymous

Guest
Has anyone called the Compliance Hotline regarding the recent "pressure" to go into locations that don't allow non-patients? My boss is pressuring me to go into AZ and NM which are hot spots for COVID. The medical locations are on lockdown to non-personal and non-patients. I wonder if the hotline could assist me?
 






Has anyone called the Compliance Hotline regarding the recent "pressure" to go into locations that don't allow non-patients? My boss is pressuring me to go into AZ and NM which are hot spots for COVID. The medical locations are on lockdown to non-personal and non-patients. I wonder if the hotline could assist me?

If contact tracing by your accounts comes back to you being an asymptomatic carrier testing positive for a new COVID variant then your liable for any and all damages and so is your company. Happened at Henry Ford, now it’s completely locked down for all reps.because some stupid rep. who was COVID+ but didn’t know it infected HCP’s, and patients, how would you like to have that on your GNX or Symplr. credentials? I would call HR today your boss is a wack job.
 






I understand the pressure from management is exhausting. I think you meant "non-personnel" instead of non-personal. The Compliance Hotline may offer guidance. If your manager starts documenting things via email and such, it might be worth a call.
 












What is the number to call when all the new senior leadership being hired are complete and total dumbasses who don't know anything about our biz? Trying to find THAT #
 






If contact tracing by your accounts comes back to you being an asymptomatic carrier testing positive for a new COVID variant then your liable for any and all damages and so is your company. Happened at Henry Ford, now it’s completely locked down for all reps.because some stupid rep. who was COVID+ but didn’t know it infected HCP’s, and patients, how would you like to have that on your GNX or Symplr. credentials? I would call HR today your boss is a wack job.
 






U.S. panel to review heart inflammation cases after Pfizer, Moderna vaccines

Wed, June 23, 2021, 7:00 AM·2 min read
By Manojna Maddipatla

June 23 (Reuters) - Advisers to the U.S. Centers for Disease Control and Prevention (CDC) are set to meet on Wednesday to assess the possibility of a link between rare cases of heart inflammation and the mRNA COVID-19 vaccines from Pfizer and partner BioNTech and from Moderna.

The CDC has been investigating cases of heart inflammation mainly in young men for several months. The Israeli health ministry earlier this month said it saw a possible link between such cases and Pfizer's COVID-19 vaccine.

During the committee meeting, set to begin at 11 a.m. ET (1500 GMT), the agency will present details of more than 300 confirmed cases of myocarditis and pericarditis reported to CDC and the Food and Drug Administration among the over 20 million adolescents and young adults vaccinated in the United States, CDC Director Rochelle Walensky said during a White House briefing last week.

The CDC earlier this month said it was still evaluating the risk from the condition and did not confirm a causal relationship between the vaccines and the heart issue.

The agency, however, said a higher-than-expected number of young men have experienced heart inflammation after their second dose of the mRNA COVID-19 shots, with more than half the cases reported in people between the ages of 12 and 24.

The Advisory Committee on Immunization Practices (ACIP) will discuss the benefits of the mRNA vaccines versus the potential risk to adolescents and young adults from the heart condition, according to the agency's agenda. https://www.cdc.gov/vaccines/acip/meetings/downloads/agenda-archive/agenda-2021-06-23-508.pdf

Although health officials in Israel have determined that there is likely a link between vaccination and the heart inflammation, concerns about the more infectious Delta coronavirus variant have prompted the country to urge 12-to 15-year olds get vaccinated.

Pfizer, whose vaccine has been authorized for use in Americans as young as 12, previously said it had not observed a higher rate of heart inflammation than would normally be expected in the general population.

Moderna had said it could not identify a causal association with the heart inflammation cases and its vaccine.

Over 138 million Americans have so far been fully vaccinated with one of the two mRNA vaccines, according to CDC data as of Monday.